Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy

J Clin Exp Hematop. 2018 Dec 13;58(4):184-187. doi: 10.3960/jslrt.18027. Epub 2018 Oct 10.
No abstract available

Keywords: BRAF V600E mutation; EPOCH; Langerhans cell sarcoma; Merkel cell polyoma virus.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Humans
  • Langerhans Cell Sarcoma / drug therapy*
  • Langerhans Cell Sarcoma / pathology
  • Male
  • Prednisone / administration & dosage
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Vincristine / administration & dosage

Substances

  • Vincristine
  • Etoposide
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • EPOCH protocol